In Meghalaya, superstitions add to delayed care for cancer patients
An “evil eye” or “toxic vibes” from a person believed to have bad intent is believed to be among the causes of cancer, a ...
Pharmaceutical Technology4d
Mosedipimod by Enzychem Lifesciences for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Mosedipimod is under clinical development by Enzychem Lifesciences and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.